Fish as Model Organism for the Identification of Marine Bioactive Compounds
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 4209
Special Issue Editor
Interests: biomedicine; model organism; bone development; extracts from marine organisms; colorectal cancer; biomarker; vitamin
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
Zebrafish (Danio rerio) and medaka (Oryzias latipes) are currently used as model organisms for the screening of molecules of interest for biomedical and pharmaceutical applications, and, in particular, for the identification of compounds capable of rescuing fish phenotypes mimicking human diseases. The marine environment, with its large diversity of habitats, hosts a plethora of species with a large diversity of physiological adaptations, which are the source of structurally unique natural products. In recent years, a number of molecules/extracts with specific biomedical applications have been isolated from marine organisms, and these proven to be effective in targeting prevalent and rare diseases or as sources to develop new analgesics, anti-inflammatory or antidiabetic drugs, to name only a few. The present Special Issue aims to bring together articles presenting a comprehensive overview of the use of fish as model organisms to identify marine derived compounds of biomedical interest.
Dr. M. Leonor Cancela
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine drugs
- in vitro experiment
- drug discovery
- bioactive compounds
- marine organisms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
